Frequency of Food Allergy Confirm by Oral Food Challenge Among Foods Avoidance in Atopic Dermatitis Children
NCT06947252 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2025-04-27
Summary
Atopic dermatitis can be caused by several factors, including food allergy. Currently, the diagnosis of food allergy often performing skin tests and measuring specific IgE foods that many studies have shown that about 53% of children with atopic dermatitis have food sensitization, result in avoidance of food intake. But only 15% are confirmed to have a true food allergy, so the purpose of our study is to find the prevalence of food allergy in Thai children with atopic dermatitis who are avoiding some foods, using the oral food challenge to confirm the diagnosis to reduce unnecessary food avoidance and prevent complications from inappropriate dietary restrictions
Conditions
- Atopic Dermatitis
- Food Allergies
Interventions
- DIAGNOSTIC_TEST
-
Oral food challenge test
Oral food challenge test at home or in the hospital
Sponsors & Collaborators
-
Mahidol University
lead OTHER
Principal Investigators
-
Punchama Pacharn · Mahidol University, Siriraj Hospital, Thailand
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Max Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-29
- Primary Completion
- 2029-06-30
- Completion
- 2029-06-30
Countries
- Thailand
Study Locations
More Related Trials
-
Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project
NCT06300697 ·Status: RECRUITING ·Phase: NA
-
Skin Barrier Abnormalities and Oxidative Stress Response
NCT04606615 ·Status: UNKNOWN
-
Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food Allergens
NCT00557284 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy
NCT03089476 ·Status: WITHDRAWN ·Phase: NA
-
Study to Evaluate the Use of RHT-3201 in SCORAD Reduction in Young Patients With Atopic Dermatitis
NCT03907228 ·Status: UNKNOWN ·Phase: NA
-
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
NCT03687359 ·Status: ACTIVE_NOT_RECRUITING
-
The Potential Role of Compounds Derived From Ultra-processed Foods in the Pathogenesis of Atopic Dermatitis in Pediatric Age
NCT06996327 ·Status: RECRUITING
-
Does Treatment With Montelukast Improve Symptoms of Atopic Dermatitis in Children?
NCT02534467 ·Status: COMPLETED ·Phase: PHASE4
-
The Factors Affecting Atopic Dermatitis in Children Age 1-3
NCT04218877 ·Status: COMPLETED
-
Effect of Oral Steroids on Skin Outcomes in Atopic Dermatitis
NCT02908698 ·Status: TERMINATED ·Phase: NA
-
Moisturizer to Prevent Atopic Dermatitis
NCT03808532 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic Dermatitis
NCT04462055 ·Status: TERMINATED
-
A Study Comparing the Efficacy of Two Topical Steroid Application Regimens in Pediatric Patients With Atopic Dermatitis
NCT01675232 ·Status: COMPLETED ·Phase: NA
-
Emollients in the Management of Atopic Dermatitis
NCT01779258 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Results of Regularly Applied Emollient - Spray in Atopic Dermatitis Therapy
NCT02763722 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Topical Coal Tar in Children With Atopic Dermatitis
NCT03461302 ·Status: UNKNOWN ·Phase: PHASE4
-
Outcome of Specific IgE Level in Children With IgE-mediated Wheat Allergy After Stop Using Wheat Containing Skin Care
NCT04013763 ·Status: TERMINATED ·Phase: NA
-
Study of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE Levels
NCT00616096 ·Status: COMPLETED ·Phase: NA
-
Effects of Treatments on Atopic Dermatitis
NCT01631617 ·Status: RECRUITING ·Phase: PHASE2
-
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
NCT03796676 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
NCT02916888 ·Status: COMPLETED
-
Sublingual Immunotherapy in Patients With Atopic Dermatitis
NCT01471119 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Anti-IgE in Severe Childhood Eczema
NCT02300701 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis
NCT03351777 ·Status: UNKNOWN ·Phase: PHASE2
-
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
NCT03257644 ·Status: COMPLETED ·Phase: PHASE1